9. March 2023

Liver Systems Medicine Cancer – LiSyM-Cancer – is a multidisciplinary research network funded by the Federal Ministry of Education and Research (BMBF) within the Framework of the National Decade Against Cancer. The funding period is July 2021 until July 2024.

In the LiSyM-Cancer network, molecular and cell biologists, clinical researchers and experts in mathematical modeling from all over Germany are jointly conducting research to investigate the development of liver cancer from pre-existing conditions such as non-alcoholic fatty liver or liver cirrhosis. The aim of the joint project is to identify relevant biomarkers to diagnose and prevent hepatocellular carcinoma (HCC) at early stages.

The LiSyM-Cancer research network builds on the achievements of the previous network LiSyM and is extending the research focus to liver cancer. SDBV is responsible for central data management including LiSyM SEEK. Furthermore, the program management is allocated to SDBV.

Switch to the German homepage or stay on this page